MICHAEL FRIES, Head, Biostatistics, CSL Behring

Michael Fries is the head of Biostatistics at CSL Behring. Michael earned his Ph.D. from the State University of New York at Buffalo and has over 20+ years of biostatistics drug development experience from non/pre-clinical to phase 4 with more than ten years in leadership positions. Michael was first involved in specific statistical questions in safety when he helped establish the PSAP process in GSK. He then joined the American Statistical Association Biopharmaceutical Safety Working Group, where he has primarily participated in the Bayesian Methods area and supported work on developing the ASAP.